CAS 118428-37-8

l-Pimobendan

Description:

L-Pimobendan is a pharmacological compound primarily used in veterinary medicine, particularly for the treatment of heart failure in dogs. It functions as a positive inotropic agent, enhancing the contractility of the heart muscle, and also possesses vasodilatory properties, which help reduce the workload on the heart. The substance acts by inhibiting phosphodiesterase III and sensitizing cardiac myofilaments to calcium, thereby improving cardiac output. L-Pimobendan is characterized by its relatively low solubility in water, which influences its formulation and administration. It is typically administered orally or intravenously, depending on the clinical scenario. The compound is known for its favorable safety profile, although potential side effects may include gastrointestinal disturbances and arrhythmias. Its efficacy in improving the quality of life and exercise tolerance in affected animals has made it a valuable therapeutic option in veterinary cardiology. As with any medication, it is essential to use L-Pimobendan under veterinary supervision to ensure appropriate dosing and monitoring of the patient's response.

Formula: C₁₉H₁₈N₄O₂

Synonyms:

• (-)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone
• (-)-UD-CG 115BS
• (-)-Pimobendan
• 3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (-)-

Pimobendan, (-)-

CAS: 118428-37-8

Pimobendan, (-)- is an inodilator of oral calcium-sensitizing.

Formula: C₁₉H₁₈N₄O₂

Color and Shape: Solid

Molecular weight: 334.37

Ref: TM-T34067

I-Pimobendan

CAS: 118428-37-8

Formula: C₁₉H₁₈N₄O₂

Molecular weight: 334.38

Ref: ST-EA-CP-P90009